Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Malekroudi et al
Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Malekroudi et al. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726003535?dgcid=rss_sd_all
Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Malekroudi et al. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S0003496726003535?dgcid=rss_sd_all
“Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Malekroudi et al.” Annals of the Rheumatic Diseases.
@article{article97434,
title = {Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Malekroudi et al},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726003535?dgcid=rss_sd_all}
}
Objective Black patients with systemic sclerosis (scleroderma) have more severe disease than White patients. We investigated whether racial differences in therapeutic responses to mycophenolate mofetil (MMF) could explain this...